Stay updated on Rucaparib + Nivolumab in Advanced Biliary Tract Cancer Clinical Trial
Sign up to get notified when there's something new on the Rucaparib + Nivolumab in Advanced Biliary Tract Cancer Clinical Trial page.

Latest updates to the Rucaparib + Nivolumab in Advanced Biliary Tract Cancer Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe page's revision tag was updated from v3.6.2 to v3.6.3, signaling a minor version update to the page rendering.SummaryDifference0.1%

- Check15 days agoChange DetectedThe page now shows revision v3.6.2, replacing the previous v3.6.0, indicating a newer revision in the page's history.SummaryDifference0.1%

- Check30 days agoChange DetectedEnrollment status now includes a 'No longer looking for participants' notice, signaling that the study is not accepting new participants. In addition, new help and navigation sections (How to Read a Study Record, Common Questions, How to Join a Study) were added to assist users in understanding and engaging with the study details.SummaryDifference0.4%

- Check37 days agoChange DetectedThe page's revision tag changed from v3.5.4 to v3.5.5, signaling a minor update to the study record.SummaryDifference0.1%

- Check58 days agoChange DetectedThe revision label on the page was updated from v3.5.3 to v3.5.4, indicating a minor update to the study record metadata on ClinicalTrials.gov.SummaryDifference0.1%

- Check79 days agoChange DetectedThe page’s displayed site revision/version number has been updated from v3.5.2 to v3.5.3, reflecting a maintenance or release change rather than an update to the clinical trial record content.SummaryDifference0.1%

Stay in the know with updates to Rucaparib + Nivolumab in Advanced Biliary Tract Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Rucaparib + Nivolumab in Advanced Biliary Tract Cancer Clinical Trial page.